Week in Review: New life in Montana, rule tweaks in Oregon & obstacles in New England

Bart Schaneman  | December 9, 2016

By Bart Schaneman and Omar Sacirbey 

Montana’s medical marijuana industry is reactivated, Oregon adjusts its testing regulations, and New England’s adult-use industry encounters obstacles.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Bart Schaneman  |
December 9, 2016

New Market: Smooth rollout expected for Arkansas MMJ industry

Bart Schaneman  | December 7, 2016

By Bart Schaneman

The Arkansas medical marijuana industry is expected to experience a smooth launch and will likely serve a small, but not tiny, market.

After a previous legalization measure failed narrowly in 2012, voters in the Bible Belt state passed an initiative on Nov. 8 to allow the use, cultivation and sale of medical cannabis.

Bart Schaneman  |
December 7, 2016

Alaska adult-use cannabis market on track, despite supply hiccups

John Schroyer  | December 6, 2016

By John Schroyer

Alaska, the nation’s newest adult-use marijuana market, is slowly but steadily getting up and running, although many shops are running short on product because demand exceeds supply.

As of Nov. 29, 61 cannabis business licenses had been issued in the state, including 29 that are currently operational.

John Schroyer  |
December 6, 2016

Chart: Healthy markups for MJ strains with celebrity names

Eli McVey  | December 5, 2016

By Eli McVey

Celebrity-branded marijuana strains are commanding a premium in recreational markets by capitalizing on name recognition and sophisticated branding.

The average markup of a celebrity-branded strain versus its unbranded counterpart is approximately 24%, which often equates to $5-$10 more per eighth, according to an analysis by Marijuana Business Daily.

Eli McVey  |
December 5, 2016

Week in Review: Lift for New York market, anti-MJ Trump choice & Canada rec development

John Schroyer  | December 2, 2016

By Omar Sacirbey, John Schroyer and Bart Schaneman

New York’s lagging medical cannabis trade receives some good news, Donald Trump picks another marijuana critic for his cabinet, and Canada considers giving MMJ companies a leg up in the recreational market.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
December 2, 2016

Testing, supply issues ‘could be death knell’ for Oregon MJ market

Omar Sacirbey  | December 1, 2016

By Omar Sacirbey

Strict marijuana testing standards and a dearth of labs have created a supply shortage for Oregon’s marijuana businesses, resulting in half-empty shelves, plunging revenue and possible layoffs. Many businesses are even closing.

Omar Sacirbey  |
December 1, 2016